Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

611

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Obesity
Interventions
DRUG

Zonisamide CR and Bupropion SR

Zonisamide SR and Bupropion SR

OTHER

Placebo

Identical placebo

Trial Locations (15)

10021

Comprehensive Weight Control Program, New York

20037

George Washington University Weight Management Program, Washington D.C.

28211

Center for Nutrition and Preventive Medicine, Charlotte

29425

MUSC Weight Mnagement Center, Charleston

30909

CSRA Partners in Health, Inc, Augusta

36532

SelfCenter, PC, Fairhope

62704

Springfield Diabetes and Endocrine Center, Springfield

70808

Pennington Biomedical Research Center, Baton Rouge

75230

The Cooper Institute, Dallas

75246

Baylor Endocrine Center, Dallas

80220

Center for Human Nutrition University of Colorado Health Sciences Center, Denver

89557

Center for Nutrition and Metabolic Diseases, Reno

90095

UCLA Center for Human Nutrition, Los Angeles

92130

Scripps Clinic Del Mar, San Diego

02118

Nutrition and Weight Mangement Center Boston Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Orexigen Therapeutics, Inc

INDUSTRY